Merck MRK
NYSE MRK
$149.18 -3.05 (-2.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Merck (MRK) Net Margin (2009 - 2026)

Merck (MRK) posted quarterly Net Margin of 25.84% for Q1 2026, down 5859.0% year-over-year from 0.45% in Q1 2025, and down 243.09% quarter-over-quarter from 18.06% in Q4 2025.

Merck (MRK) Net Margin (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Net Margin for 17 consecutive years, with 25.84% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Margin fell 5859.0% year-over-year to 25.84%; the TTM figure through Mar 2026 stood at 13.64% (down 1366.0% YoY), while the FY2025 annual figure was 28.09%, up 139.0% from the prior year.
  • Net Margin slipped to 25.84% in Q1 2026 per MRK's latest filing, from 18.06% in the prior quarter.
  • Across five years, Net Margin topped out at 33.89% in Q2 2024 and bottomed at 39.72% in Q2 2023.
  • Historically, Net Margin has averaged 14.98% across 4 years, with a median of 23.96% in 2024.
  • Annual changes were most pronounced in 2024 — Net Margin surged 7361 bps — and 2026, when it tumbled 5859 bps.
  • Merck's Net Margin stood at 8.38% in 2023, then surged by 386 bps to 23.96% in 2024, then slipped by 25 bps to 18.06% in 2025, then plunged by 243 bps to 25.84% in 2026.
  • Business Quant data shows MRK's Net Margin at 25.84% in Q1 2026, 18.06% in Q4 2025, and 33.5% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 21.86%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 21.28%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -8.05%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 22.65%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 16.30%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 23.62%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -134.51%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -1.58%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 5.17%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 2.96%

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.05%
Mar 31, 2026 -25.84%
Dec 31, 2025 18.06%
Sep 30, 2025 33.50%
Jun 30, 2025 28.01%
Mar 31, 2025 32.75%
Dec 31, 2024 23.96%
Sep 30, 2024 18.98%
Jun 30, 2024 33.89%
Mar 31, 2024 30.22%
Dec 31, 2023 -8.38%
Sep 30, 2023 29.76%
Jun 30, 2023 -39.72%
Mar 31, 2023 19.50%
Dec 31, 2021 -0.44%
Jun 30, 2021 2.91%
Mar 31, 2021 4.08%
Dec 31, 2020 4.78%
Sep 30, 2020 5.66%
Jun 30, 2020 7.11%